SRSF2 and myeloid neoplasm: The majority of ASXL1-mutated patients had other concurrent gene mutations, and splicing factors (SRSF2, U2AF1, ZRZR2, SF3B1) were most frequently mutated in myeloid malignancies [6, 7].